1 active not recruiting, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Terminated 1 |
Follow SI-BONE, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction Use of iFuse TORQ - Sacroiliac Joint Dysfunction, Sacroiliac; Fusion | Phase 4 | Active not recruiting | SI-BONE, Inc. | 110 | 2023-05-23 | 2026-08-06 |
| Validity and Reliability of Diagnostic Findings of SI Joint Blocking 0.75% bupivacaine, .75% bupivacaine - SI Joint Pain | Phase 4 | Terminated | SI-BONE, Inc. | 28 | 2013-04-22 | 2019-09-24 |
Bupivacaine (1)
United States (2)
Aaron Calodney, MD (1) · Stacie Tran, MPH (1)